Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT
Open Access
- 31 July 2015
- journal article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 5 (1), 12657
- https://doi.org/10.1038/srep12657
Abstract
Nicotinamide phosphoribosyltransferase (NAMPT) is a promising antitumor target. Novel NAMPT inhibitors with diverse chemotypes are highly desirable for development of antitumor agents. Using high throughput screening system targeting NAMPT on a chemical library of 30000 small-molecules, we found a non-fluorescent compound F671-0003 and a fluorescent compound M049-0244 with excellent in vitro activity (IC50: 85 nM and 170 nM respectively) and anti-proliferative activity against HepG2 cells. These two compounds significantly depleted cellular NAD levels. Exogenous NMN rescued their anti-proliferative activity against HepG2 cells. Structure-activity relationship study proposed a binding mode for NAMPT inhibitor F671-0003 and highlighted the importance of hydrogen bonding, hydrophobic and π-π interactions in inhibitor binding. Imaging study provided the evidence that fluorescent compound M049-0244 (3 μM) significantly stained living HepG2 cells. Cellular fluorescence was further verified to be NAMPT dependent by using RNA interference and NAMPT over expression transgenic mice. Our findings provide novel antitumor lead compounds and a “first-in-class” fluorescent probe for imaging NAMPT.This publication has 32 references indexed in Scilit:
- Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) InhibitorsJournal of Medicinal Chemistry, 2013
- Loss of AMP-Activated Protein Kinase-α2 Impairs the Insulin-Sensitizing Effect of Calorie Restriction in Skeletal MuscleDiabetes, 2012
- Inhibition of Nicotinamide Phosphoribosyltransferase: CELLULAR BIOENERGETICS REVEALS A MITOCHONDRIAL INSENSITIVE NAD POOLOnline Journal of Public Health Informatics, 2010
- Nampt: linking NAD biology, metabolism and cancerTrends in Endocrinology & Metabolism, 2009
- Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotideCardiovascular Research, 2008
- The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitorInvestigational New Drugs, 2007
- Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell SurvivalCell, 2007
- Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3weeks in solid tumours: An ECSG/EORTC studyEuropean Journal of Cancer, 2005
- Formal Hydride Transfer Mechanism for Photoreduction of 3-Phenylquinoxalin-2-ones by Amines. Association of 3-Phenylquinoxalin-2-one with Aliphatic AminesThe Journal of Organic Chemistry, 2000
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999